Testing LAE103 alone or with LAE102 in healthy adults with extra weight
Part of Hormones & metabolism clinical trials.
This trial is testing a new drug called LAE103 (and LAE102) in healthy people who are overweight or obese. It aims to see if the drug is safe and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old (or a woman aged 45–75 for Part B).
- Your body mass index (BMI) is between 25 and 40 (or 20–35 for Part B).
- You are generally healthy, with no major medical conditions.
- You are not pregnant, not nursing, and use effective birth control if applicable.
- Your blood tests show no HIV, hepatitis B or C, and you have normal kidney and heart function.
- You haven't taken weight loss medications, GLP-1 drugs, or had major changes in weight or lifestyle recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, CG-0416, in healthy people to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.
This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.
This study tests a new medicine called LAE102 in two groups: healthy volunteers and people who are overweight or obese. The goal is to see if it is safe and how the body processes it.
This trial tests if adding LAE102 to tirzepatide (a weight loss drug) helps people with obesity lose more weight than tirzepatide alone. It is for adults who have tried diet and exercise but still struggle to lose weight.
This study tests a new injection called SA030 to help people who are overweight or obese. The goal is to see if the study drug is safe and how it works in the body.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
Hear when a new Overweight and Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.